Skip to main content

Advertisement

Log in

HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

To investigate the frequency of hepatitis B virus (HBV)-related events after allogeneic HCT in a moderate endemic area for HBV infection. The data of 197 patients who underwent allogeneic hematopoetic stem cell transplatation (HCT) from September 2003 through December 2010 were reviewed retrospectively with respect to HBV-related events. Resolved HBV infection was described as negative HBsAg, positive HBcAb, and positive HBsAb. Latent HBV infection was defined in patients with HBcAb positivity in the abscence of HBV DNA and HBsAb. Hepatitis B naive patients are defined as the patiens with no serological or molecular marker related to HBV. Seropositive patients were the patients with positive HBsAg and HBV-DNA. Median age was 28 (range, 15–64) years, with 128 male and 69 female patients. Median follow-up of the cohort was 8 (range, 0.5–78) months. We detected HBV-related events in 7 (3.6 %) recipients after allogeneic HCT. Five (71.4 %) of these events were HBV reactivation, while two cases (28.6 %) had acute hepatitis B infection. Four of the five reactivations were in the seropositive group (80 %), while one ocurred in a patient with resolved hepatitis. Two patients who developed acute hepatitis B were HBV naive and previously immunized patients, respectively. Hepatitis B virus reactivation remains a problem in seropositive patients and might require more effective treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dienstag JL, Hepatitis B (2008) Virus infection. N Engl J Med 359:1486–1500

    Article  PubMed  CAS  Google Scholar 

  2. Hu KQ (2002) Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 9:243–257

    Article  PubMed  Google Scholar 

  3. Emektaş G, Çavuşlu S, Öncül O, Artuk C, Aksoy A (2006) Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in turkey. Eur J Epidemiol 21:299–305

    Article  Google Scholar 

  4. Liang R (2009) How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood 113:3147–3153

    Article  PubMed  CAS  Google Scholar 

  5. Hammond SP, Borchelt AM, Ukomadu C, Ho VT, Baden LR, Marty FM (2009) Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15:1049–1059

    Article  PubMed  Google Scholar 

  6. Knoll A, Boehm S, Hahn J, Holler E, Jilg W (2004) Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 33:925–929

    Article  PubMed  CAS  Google Scholar 

  7. Ramos CA, Saliba RM, de Pádua L, Silva OK, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Nieto Y, Champlin RE, de Lima M (2010) Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 16:686–694

    Article  PubMed  CAS  Google Scholar 

  8. McDonald GB (2010) Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology 51:1450–1460

    Article  PubMed  Google Scholar 

  9. Lalazar G, Rund D, Shouval D (2007) Screening, prevention and treatment of viral hepatitis B reactivationin patients with haematological malignancies. Br J Haematol 136:699–712

    Article  PubMed  CAS  Google Scholar 

  10. Çeneli O, Ozkurt ZN, Acar K, Rota S, Aki SZ, Yeğin ZA, Yağci M, Ozenirler S, Sucak GT (2010) Hepatitis related events in autologous hematopoietic stem cell transplantation recipients. World J Gastroenterol 16:1765–1771

    Article  PubMed  Google Scholar 

  11. Knoll S, Boehm J, Hahn EH, Jilg W (2007) Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. J Viral Hepat 14:478–483

    Article  PubMed  CAS  Google Scholar 

  12. Dhédin N, Douvin C, Kuentz M, Saint Marc MF, Reman O, Rieux C, Bernaudin F, Norol F, Cordonnier C, Bobin D, Metreau JM, Vernant JP (1998) Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 66:616–619

    Article  PubMed  Google Scholar 

  13. Locasciulli A, Bruno B, Alessandrino EP, Meloni G, Arcese W, Bandini G, Cassibba V, Rotoli B, Morra E, Majolino I, Alberti A, Bacigalupo A (2003) Viral infections hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Bone Marrow Transplant 31:295–300

    Article  PubMed  CAS  Google Scholar 

  14. Lau GK, Liang R, Chiu EK, Lee CK, Lam SK (1997) Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant 19:795–799

    Article  PubMed  CAS  Google Scholar 

  15. Hui CK, Lie A, Au WY, Leung YH, Ma SY, Cheung WW, Zhang HY, Chim CS, Kwong YL, Liang R, Lau GK (2005) A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood 106:464–469

    Article  PubMed  CAS  Google Scholar 

  16. Hsiao LT, Chiou TJ, Gau JP, Liu JH, Tzeng CH, Chen PM (2009) Hepatitis B infection in haematopoietic stem cell transplantation: still unresolved. Hong Kong Med J 15(Suppl 3):42–44

    PubMed  CAS  Google Scholar 

  17. Katz LH, Fraser A, Gafter-Gvili A, Leibovici L, Tur-Kaspa R (2008) Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis. J Viral Hepat 15:89–102

    PubMed  CAS  Google Scholar 

  18. Yeo W, Johnson PJ (2006) Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology 43:209–220

    Article  PubMed  CAS  Google Scholar 

  19. Lau GK, He ML, Fong DY, Bartholomeusz A, Au WY, Lie AK, Locarnini S, Liang R (2002) Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation. Hepatology 36:702–709

    Article  PubMed  CAS  Google Scholar 

  20. Sugauchi F, Tanaka Y, Kusumoto S, Matsuura K, Sugiyama M, Kurbanov F, Ueda R, Mizokami M (2011) Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy. J Med Virol 83:412–418

    Article  PubMed  CAS  Google Scholar 

  21. Lee YC, Young KC, Su WC, Tsao CJ, Chen TY (2004) Emergence of YMDD mutant Hepatitis B virus after allogeneic stem cell transplantation from a HBsAG-positive donor during lamivudine prophylaxis. Haematologica 89:30–31

    Google Scholar 

  22. Fouillard L, Serfaty L, Gozlan J (2006) Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplant 37:625–626

    Article  PubMed  CAS  Google Scholar 

  23. Seth P, Alrajhi AA, Kagevi I, Chaudhary MA, Colcol E, Sahovic E, Aljurf M, Gyger M (2002) Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant 30:189–194

    Article  PubMed  CAS  Google Scholar 

  24. Matsue K, Aoki T, Odawara J, Fujiwara H, Iwama K, Kimura S, Yamakura M, Takeuch M (2009) High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients. Eur J Haematol 83(4):357–364

    Article  PubMed  CAS  Google Scholar 

  25. Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ (2006) Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations. J Viral Hepat 13(9):591–596

    Article  PubMed  CAS  Google Scholar 

  26. Picardi M, De Rosa G, Selleri C, Pane F, Rotoli B, Muretto P (2006) Clinical relevance of intrahepatic hepatitis B virus DNA in HBsAg-negative HBcAb-positive patients undergoing hematopoietic stem cell transplantation for hematological malignancies. Transplantation 82:141–142

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare that they do not have conflict of interest

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gülsan Türköz Sucak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Çakar, M.K., Suyanı, E., Sucak, G.T. et al. HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey. Ann Hematol 92, 395–402 (2013). https://doi.org/10.1007/s00277-012-1620-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1620-1

Keywords

Navigation